loadpatents
name:-0.052554130554199
name:-0.029531002044678
name:-0.049278020858765
Merghoub; Taha Patent Filings

Merghoub; Taha

Patent Applications and Registrations

Patent applications and USPTO patent grants for Merghoub; Taha.The latest application filed is for "anti-ctla-4 antibodies and methods of use thereof".

Company Profile
51.30.51
  • Merghoub; Taha - Jersey City NJ
  • Merghoub; Taha - New York NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Antibodies and methods of use thereof
Grant 11,447,557 - Wilson , et al. September 20, 2
2022-09-20
Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors
Grant 11,426,460 - Deng , et al. August 30, 2
2022-08-30
Anti-ctla-4 Antibodies And Methods Of Use Thereof
App 20220267443 - Van DIJK; Marc ;   et al.
2022-08-25
Anti-GITR antibodies and methods of use thereof
Grant 11,401,335 - Gonzalez , et al. August 2, 2
2022-08-02
Use Of Mva Or Mvadeltae3l As Immunotherapeutic Agents Against Solid Tumors
App 20220211785 - DENG; Liang ;   et al.
2022-07-07
Vaccinia Virus Mutants Useful For Cancer Immunotherapy
App 20220186192 - Deng; Liang ;   et al.
2022-06-16
Anti-OX40 antibodies and anti-GITR antibodies
Grant 11,359,028 - Wilson , et al. June 14, 2
2022-06-14
Anti-PD-1 antibodies and methods of use thereof
Grant 11,345,755 - Van Dijk , et al. May 31, 2
2022-05-31
Vectors comprising nucleic acids encoding anti-OX40 antibodies
Grant 11,332,536 - Van Dijk , et al. May 17, 2
2022-05-17
Anti-ox40 Antibodies And Methods Of Use Thereof
App 20220098316 - VAN DIJK; Marc ;   et al.
2022-03-31
Recombinant MVA or MVA.DELTA.E3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors
Grant 11,285,209 - Deng , et al. March 29, 2
2022-03-29
Anti-CTLA-4 antibodies and methods of use thereof
Grant 11,267,889 - Van Dijk , et al. March 8, 2
2022-03-08
Recombinant Poxviruses For Cancer Immunotherapy
App 20220056475 - DENG; Liang ;   et al.
2022-02-24
Use of MVA or MVA.DELTA.E3L as immunotherapeutic agents against solid tumors
Grant 11,253,560 - Deng , et al. February 22, 2
2022-02-22
Vaccinia virus mutants useful for cancer immunotherapy
Grant 11,242,509 - Deng , et al. February 8, 2
2022-02-08
Anti-ox40 Antibodies And Methods Of Use Thereof
App 20210324097 - WILSON; Nicholas S. ;   et al.
2021-10-21
Anti-OX40 antibodies
Grant 11,136,404 - Van Dijk , et al. October 5, 2
2021-10-05
Anti-ctla-4 Antibodies And Methods Of Use Thereof
App 20210205451 - van Dijk; Marc ;   et al.
2021-07-08
Inhibition of CTLA-4 and/or PD-1 For Regulation of T Cells
App 20210179714 - WOLCHOK; Jedd ;   et al.
2021-06-17
Heat-inactivated Vaccinia Virus As A Vaccine Immune Adjuvant
App 20210177964 - DENG; Liang ;   et al.
2021-06-17
Antibodies And Methods Of Use Thereof
App 20210171648 - WILSON; Nicholas S. ;   et al.
2021-06-10
Anti-CTLA-4 antibodies and methods of use thereof
Grant 11,013,802 - van Dijk , et al. May 25, 2
2021-05-25
Anti-gitr Antibodies And Methods Of Use Thereof
App 20210070872 - SEIBERT; Volker ;   et al.
2021-03-11
Anti-CTLA-4 antibodies and methods of use thereof
Grant 10,912,831 - van Dijk , et al. February 9, 2
2021-02-09
Oncolytic Vaccinia Virus Expressing Immune Checkpoint Blockade For Cancer Immunotherapy
App 20210023151 - DENG; Liang ;   et al.
2021-01-28
Anti-ctla-4 Antibodies And Methods Of Use Thereof
App 20210023214 - van Dijk; Marc ;   et al.
2021-01-28
Antibodies and methods of use thereof
Grant 10,836,830 - Wilson , et al. November 17, 2
2020-11-17
Anti-ctla-4 Antibodies And Methods Of Use Thereof
App 20200354455 - VAN DIJK; Marc ;   et al.
2020-11-12
Anti-pd-1 Antibodies And Methods Of Use Thereof
App 20200354454 - VAN DIJK; Marc ;   et al.
2020-11-12
Anti-GITR antibodies and methods of use thereof
Grant 10,829,559 - Seibert , et al. November 10, 2
2020-11-10
Anti-gitr Antibodies And Methods Of Use Thereof
App 20200339698 - GONZALEZ; Ana M. ;   et al.
2020-10-29
Anti-GITR antibodies and methods of use thereof
Grant 10,800,849 - Gonzalez , et al. October 13, 2
2020-10-13
Antibodies And Methods Of Use Thereof
App 20200317797 - WILSON; Nicholas S. ;   et al.
2020-10-08
Anti-ox40 Antibodies And Methods Of Use Thereof
App 20200317796 - VAN DIJK; Marc ;   et al.
2020-10-08
Recombinant Mva Or Mvadele3l Expressing Human Flt3l And Use Thereof As Immuno-therapeutic Agents Against Solid Tumors
App 20200316198 - DENG; Liang ;   et al.
2020-10-08
Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human FLT3L or GM-CSF for cancer immunotherapy
Grant 10,765,711 - Deng , et al. Sep
2020-09-08
Anti-ox40 Antibodies And Methods Of Use Thereof
App 20200270356 - VAN DIJK; Marc ;   et al.
2020-08-27
Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors
Grant 10,736,962 - Deng , et al. A
2020-08-11
Replication Competent Attenuated Vaccinia Viruses With Deletion Of Thymidine Kinase With And Without The Expression Of Human Flt
App 20200237839 - DENG; Liang ;   et al.
2020-07-30
Use Of Inactivated Nonreplicating Modified Vaccinia Virus Ankara (mva) As Monoimmunotherapy Or In Combination With Immume Checkp
App 20200237902 - Deng; Liang ;   et al.
2020-07-30
Neoantigens And Uses Thereof For Treating Cancer
App 20200232040 - Luksza; Marta ;   et al.
2020-07-23
Use Of Mva Or Mvadeltae3l As Immunotherapeutic Agents Against Solid Tumors
App 20200222479 - DENG; Liang ;   et al.
2020-07-16
Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors
Grant 10,639,366 - Deng , et al.
2020-05-05
Anti-gitr Antibodies And Methods Of Use Thereof
App 20200123265 - WILSON; Nicholas S. ;   et al.
2020-04-23
Nucleic acids encoding anti-OX40 antibodies
Grant 10,626,181 - Van Dijk , et al.
2020-04-21
Alphavirus Replicon Particles Expressing TRP2
App 20200113984 - WOLCHOK; Jedd D. ;   et al.
2020-04-16
Anti-ox40 Antibodies And Methods Of Use Thereof
App 20200079862 - WILSON; Nicholas S. ;   et al.
2020-03-12
Antibodies And Methods Of Use Thereof
App 20200079861 - WILSON; Nicholas S. ;   et al.
2020-03-12
Methods And Compositions For Tumor Therapy
App 20200079860 - Khalil; Danny Nejad ;   et al.
2020-03-12
Anti-GITR antibodies and methods of use thereof
Grant 10,577,426 - Gonzalez , et al.
2020-03-03
Bi-specific Activators For Tumor Therapy
App 20200055947 - Khalil; Danny Nejad ;   et al.
2020-02-20
Use of MVA or MVA.DELTA.E3L as immunotherapeutic agents against solid tumors
Grant 10,548,930 - Deng , et al. Fe
2020-02-04
Antibodies And Methods Of Use Thereof
App 20200024350 - VAN DIJK; Marc ;   et al.
2020-01-23
Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy
Grant 10,512,662 - Deng , et al. Dec
2019-12-24
Antigen-binding Proteins Targeting Melanoma Differentiation Antigens And Uses Thereof
App 20190375855 - Merghoub; Taha ;   et al.
2019-12-12
Anti-ox40 Antibodies, Anti-gitr Antibodies, And Methods Of Use Thereof
App 20190367627 - WILSON; Nicholas S. ;   et al.
2019-12-05
Anti-ox40 Antibodies And Methods Of Use Thereof
App 20190352410 - VAN DIJK; Marc ;   et al.
2019-11-21
Anti-CTLA-4 antibodies and methods of use thereof
Grant 10,479,833 - van Dijk , et al. Nov
2019-11-19
Anti-PD-1 antibodies and methods of use thereof
Grant 10,450,373 - Van Dijk , et al. Oc
2019-10-22
Anti-gitr Antibodies And Methods Of Use Thereof
App 20190309082 - SEIBERT; Volker ;   et al.
2019-10-10
Anti-ox40 Antibodies And Methods Of Use Thereof
App 20190284291 - VAN DIJK; Marc ;   et al.
2019-09-19
Anti-pd-1 Antibodies And Methods Of Use Thereof
App 20190256601 - VAN DIJK; MARC ;   et al.
2019-08-22
Anti-PD-1 antibodies and methods of use thereof
Grant 10,323,091 - van Dijk , et al.
2019-06-18
Anti-ctla-4 Antibodies And Methods Of Use Thereof
App 20190135919 - van Dijk; Marc ;   et al.
2019-05-09
Anti-GITR antibodies and methods of use thereof
Grant 10,280,226 - Seibert , et al.
2019-05-07
Anti-OX40 antibodies
Grant 10,259,882 - Van Dijk , et al.
2019-04-16
Anti-GITR Antibodies and Methods of Use Thereof
App 20190062446 - SEIBERT; Volker ;   et al.
2019-02-28
Replication Competent Attenuated Vaccinia Viruses With Deletion Of Thymidine Kinase With And Without The Expression Of Human Flt3l Or Gm-csf For Cancer Immunotherapy
App 20190054131 - DENG; Liang ;   et al.
2019-02-21
Recombinant Mva Or Mvadele3l Expressing Human Flt3l And Use Thereof As Immuno-therapeutic Agents Against Solid Tumors
App 20190046640 - DENG; Liang ;   et al.
2019-02-14
Anti-GITR Antibodies and Methods of Use Thereof
App 20190010239 - GONZALEZ; Ana M. ;   et al.
2019-01-10
Anti-GITR antibodies and methods of use thereof
Grant 10,155,818 - Seibert , et al. Dec
2018-12-18
Anti-GITR Antibodies and Methods of Use Thereof
App 20180355051 - GONZALEZ; Ana M. ;   et al.
2018-12-13
Anti-CTLA-4 antibodies and methods of use thereof
Grant 10,144,779 - van Dijk , et al. De
2018-12-04
Anti-GITR Antibodies and Methods of Use Thereof
App 20180244793 - GONZALEZ; Ana M. ;   et al.
2018-08-30
Use Of Inactivated Nonreplicating Modified Vaccinia Virus Ankara (mva) As Monoimmunotherapy Or In Combination With Immume Checkpoint Blocking Agents For Solid Tumors
App 20180236062 - Deng; Liang ;   et al.
2018-08-23
Anti-ctla-4 Antibodies And Methods Of Use Thereof
App 20180185481 - van Dijk; Marc ;   et al.
2018-07-05
Use Of Mva Or Mvadeltae3l As Immunotherapeutic Agents Against Solid Tumors
App 20180078591 - DENG; Liang ;   et al.
2018-03-22
Anti-pd-1 Antibodies And Methods Of Use Thereof
App 20170081409 - Dijk; Marc van ;   et al.
2017-03-23
Anti-ctla-4 Antibodies And Methods Of Use Thereof
App 20160368989 - Dijk; Marc van ;   et al.
2016-12-22
Anti-OX40 Antibodies and Methods of Use Thereof
App 20160347847 - VAN DIJK; Marc ;   et al.
2016-12-01
Anti-GITR Antibodies and Methods of Use Thereof
App 20150368349 - GONZALEZ; Ana M. ;   et al.
2015-12-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed